CPA4
Carboxypeptidase A4
Also known as: CBPA4_HUMAN, CPA3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UI42
- Gene
- CPA4
- Ensembl
- ENSG00000128510
- Chromosome
- 7
- Canonical length
- 421 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Centriolar satellite
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
This gene is a member of the carboxypeptidase A/B subfamily, and it is located in a cluster with three other family members on chromosome 7. Carboxypeptidases are zinc-containing exopeptidases that catalyze the release of carboxy-terminal amino acids, and are synthesized as zymogens that are activated by proteolytic cleavage. This gene could be involved in the histone hyperacetylation pathway. It is imprinted and may be a strong candidate gene for prostate cancer aggressiveness. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
421 residues, UniProt reviewed canonical sequence.
>Q9UI42|CPA4
1 MRWILFIGAL IGSSICGQEK FFGDQVLRIN VRNGDEISKL SQLVNSNNLK LNFWKSPSSF
61 NRPVDVLVPS VSLQAFKSFL RSQGLEYAVT IEDLQALLDN EDDEMQHNEG QERSSNNFNY
121 GAYHSLEAIY HEMDNIAADF PDLARRVKIG HSFENRPMYV LKFSTGKGVR RPAVWLNAGI
181 HSREWISQAT AIWTARKIVS DYQRDPAITS ILEKMDIFLL PVANPDGYVY TQTQNRLWRK
241 TRSRNPGSSC IGADPNRNWN ASFAGKGASD NPCSEVYHGP HANSEVEVKS VVDFIQKHGN
301 FKGFIDLHSY SQLLMYPYGY SVKKAPDAEE LDKVARLAAK ALASVSGTEY QVGPTCTTVY
361 PASGSSIDWA YDNGIKFAFT FELRDTGTYG FLLPANQIIP TAEETWLGLK TIMEHVRDNL
421 YLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CPA4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- skin: 54 nTPM
- esophagus: 21 nTPM
- pancreas: 12 nTPM
- cervix: 12 nTPM
- vagina: 12 nTPM
- salivary gland: 6 nTPM
Single-cell type
- salivary duct cells: 382 nCPM
- esophageal apical cells: 295 nCPM
- pancreatic acinar cells: 81 nCPM
- ocular epithelial cells: 80 nCPM
- mesothelial cells: 55 nCPM
- suprabasal keratinocytes: 35 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- hypothalamus: 5.5 nTPM
- cerebral cortex: 5 nTPM
- medulla oblongata: 3.4 nTPM
- white matter: 3.4 nTPM
- pons: 3.2 nTPM
- midbrain: 2.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.4
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.53
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CPA4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CPA4 as an antibody target. Whether an autoantibody or antibody against CPA4 could matter depends on whether native CPA4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CPA4 is annotated as secreted, so native CPA4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CPA4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...